$338 Million is the total value of Ghost Tree Capital, LLC's 58 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 105.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RETA | New | REATA PHARMACEUTICALS INCcall | $27,276,000 | – | 300,000 | +100.0% | 8.06% | – |
| XBI | New | SPDR SER TRcall | $22,863,000 | – | 300,000 | +100.0% | 6.76% | – |
| SRPT | New | SAREPTA THERAPEUTICS INCcall | $17,229,000 | – | 125,000 | +100.0% | 5.09% | – |
| TGTX | New | TG THERAPEUTICS INC | $16,544,000 | – | 1,100,000 | +100.0% | 4.89% | – |
| Buy | AMYLYX PHARMACEUTICALS INC | $13,937,000 | +7.8% | 475,000 | +35.7% | 4.12% | -25.4% | |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $13,878,000 | -23.4% | 225,000 | -4.3% | 4.10% | -47.0% |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $11,794,000 | -25.7% | 110,000 | -15.4% | 3.49% | -48.6% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $10,858,000 | -30.0% | 164,620 | -45.1% | 3.21% | -51.5% |
| AKRO | Buy | AKERO THERAPEUTICS INC | $10,522,000 | +125.9% | 275,000 | +223.5% | 3.11% | +56.4% |
| VKTX | Buy | VIKING THERAPEUTICS INC | $9,990,000 | +254.3% | 600,000 | +100.0% | 2.95% | +145.3% |
| PCVX | Buy | VAXCYTE INC | $8,433,000 | +9.9% | 225,000 | +40.6% | 2.49% | -23.9% |
| CTIC | Buy | CTI BIOPHARMA CORP | $8,400,000 | -24.5% | 2,000,000 | +8.1% | 2.48% | -47.7% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $8,270,000 | +16.0% | 60,000 | +9.1% | 2.44% | -19.7% |
| PFE | New | PFIZER INC | $8,160,000 | – | 200,000 | +100.0% | 2.41% | – |
| RVNC | Sell | REVANCE THERAPEUTICS INC | $8,053,000 | +45.4% | 250,000 | -16.7% | 2.38% | +0.7% |
| JNJ | New | JOHNSON & JOHNSON | $7,750,000 | – | 50,000 | +100.0% | 2.29% | – |
| QURE | New | UNIQURE NV | $7,553,000 | – | 375,000 | +100.0% | 2.23% | – |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $7,268,000 | +25.2% | 30,000 | +50.0% | 2.15% | -13.3% |
| XENE | New | XENON PHARMACEUTICALS INC | $7,158,000 | – | 200,000 | +100.0% | 2.12% | – |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $6,864,000 | +79.8% | 325,000 | +116.7% | 2.03% | +24.5% |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $6,364,000 | -66.5% | 70,000 | -86.0% | 1.88% | -76.8% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $6,110,000 | -26.4% | 1,000,000 | -23.1% | 1.81% | -49.1% |
| ASTRIA THERAPEUTICS INC | $5,985,000 | -10.7% | 450,000 | 0.0% | 1.77% | -38.2% | ||
| COGT | Sell | COGENT BIOSCIENCES INC | $5,935,000 | -35.8% | 550,000 | -31.2% | 1.75% | -55.6% |
| INCY | New | INCYTE CORP | $5,420,000 | – | 75,000 | +100.0% | 1.60% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $5,268,000 | – | 475,000 | +100.0% | 1.56% | – |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $5,205,000 | -42.6% | 140,000 | -30.0% | 1.54% | -60.2% |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $5,175,000 | – | 225,000 | +100.0% | 1.53% | – |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $4,452,000 | -7.6% | 175,000 | +6.1% | 1.32% | -36.1% |
| ISEE | Sell | IVERIC BIO INC | $4,258,000 | -55.8% | 175,000 | -61.1% | 1.26% | -69.4% |
| New | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $4,171,000 | – | 195,000 | +100.0% | 1.23% | – | |
| AVTE | Buy | AEROVATE THERAPEUTICS INC | $4,034,000 | +2.0% | 200,000 | +48.1% | 1.19% | -29.4% |
| BMEA | New | BIOMEA FUSION INC | $3,721,000 | – | 120,000 | +100.0% | 1.10% | – |
| ACRS | New | ACLARIS THERAPEUTICS INC | $3,438,000 | – | 425,000 | +100.0% | 1.02% | – |
| APLS | New | APELLIS PHARMACEUTICALS INCcall | $3,423,000 | – | 51,900 | +100.0% | 1.01% | – |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $3,179,000 | -59.6% | 17,500 | -56.2% | 0.94% | -72.0% |
| ETNB | New | 89BIO INC | $3,046,000 | – | 200,000 | +100.0% | 0.90% | – |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $2,294,000 | -11.2% | 275,000 | +22.2% | 0.68% | -38.5% |
| AMAM | New | AMBRX BIOPHARMA INCsponsored ads | $2,230,000 | – | 250,000 | +100.0% | 0.66% | – |
| RAIN | New | RAIN ONCOLOGY INC | $2,185,000 | – | 250,000 | +100.0% | 0.65% | – |
| New | DISC MEDICINE INC | $2,119,000 | – | 100,000 | +100.0% | 0.63% | – | |
| RNA | Buy | AVIDITY BIOSCIENCES INC | $1,919,000 | -13.5% | 125,000 | +25.0% | 0.57% | -40.1% |
| ALT | New | ALTIMMUNE INCcall | $1,688,000 | – | 400,000 | +100.0% | 0.50% | – |
| RXDX | Buy | PROMETHEUS BIOSCIENCES INC | $1,610,000 | +47.8% | 15,000 | +51.6% | 0.48% | +2.4% |
| ALPN | New | ALPINE IMMUNE SCIENCES INC | $1,544,000 | – | 200,000 | +100.0% | 0.46% | – |
| ETNB | New | 89BIO INCcall | $1,523,000 | – | 100,000 | +100.0% | 0.45% | – |
| RCUS | New | ARCUS BIOSCIENCES INC | $1,368,000 | – | 75,000 | +100.0% | 0.40% | – |
| FUSN | New | FUSION PHARMACEUTICALS INC | $1,320,000 | – | 350,000 | +100.0% | 0.39% | – |
| Buy | AADI BIOSCIENCE INC | $1,086,000 | -6.0% | 150,000 | +66.7% | 0.32% | -34.9% | |
| TARS | TARSUS PHARMACEUTICALS INC | $1,006,000 | -14.2% | 80,000 | 0.0% | 0.30% | -40.7% | |
| GERN | New | GERON CORP | $977,000 | – | 450,000 | +100.0% | 0.29% | – |
| XFOR | Sell | X4 PHARMACEUTICALS INC | $740,000 | -25.5% | 850,000 | -15.0% | 0.22% | -48.3% |
| SWTX | New | SPRINGWORKS THERAPEUTICS INC | $710,000 | – | 27,578 | +100.0% | 0.21% | – |
| KZR | Sell | KEZAR LIFE SCIENCES INC | $548,000 | -77.1% | 175,000 | -48.5% | 0.16% | -84.1% |
| FGEN | New | FIBROGEN INC | $494,000 | – | 26,500 | +100.0% | 0.15% | – |
| IMGN | New | IMMUNOGEN INC | $480,000 | – | 124,977 | +100.0% | 0.14% | – |
| BBIO | New | BRIDGEBIO PHARMA INC | $415,000 | – | 25,000 | +100.0% | 0.12% | – |
| VNDA | New | VANDA PHARMACEUTICALS INC | $85,000 | – | 12,500 | +100.0% | 0.02% | – |
| AGLE | Exit | AEGLEA BIOTHERAPEUTICS INC | $0 | – | -800,000 | -100.0% | -0.15% | – |
| DSGN | Exit | DESIGN THERAPEUTICS INC | $0 | – | -82,853 | -100.0% | -0.36% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -20,000 | -100.0% | -0.37% | – |
| RAPT | Exit | RAPT THERAPEUTICS INC | $0 | – | -125,000 | -100.0% | -1.06% | – |
| PRVB | Exit | PROVENTION BIO INC | $0 | – | -400,000 | -100.0% | -1.80% | – |
| SGEN | Exit | SEAGEN INC | $0 | – | -85,000 | -100.0% | -4.66% | – |
| QQQ | Exit | INVESCO QQQ TRunit ser 1 | $0 | – | -50,000 | -100.0% | -5.68% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.